awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39566592-EFF7E4B9-B565-4FA8-A06D-9E24C331899C
Q39566592-EFF7E4B9-B565-4FA8-A06D-9E24C331899C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39566592-EFF7E4B9-B565-4FA8-A06D-9E24C331899C
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo.
P2860
Q39566592-EFF7E4B9-B565-4FA8-A06D-9E24C331899C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39566592-EFF7E4B9-B565-4FA8-A06D-9E24C331899C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a29c984261e10efc98aef1294849b1b219e3c080
P2860
Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.